AIMC Topic: Drug Development

Clear Filters Showing 61 to 70 of 333 articles

Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development.

Current medical research and opinion
Diabetes mellitus, stemming from either insulin resistance or inadequate insulin secretion, represents a complex ailment that results in prolonged hyperglycemia and severe complications. Patients endure severe ramifications such as kidney disease, vi...

Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events.

Pharmaceutical research
OBJECTIVE: Currently, 90% of clinical drug development fails, where 30% of these failures are due to clinical toxicity. The current extensive animal toxicity studies are not predictive of clinical adverse events (AEs) at clinical doses, while current...

3D printed dosage forms, where are we headed?

Expert opinion on drug delivery
INTRODUCTION: 3D Printing (3DP) is an innovative fabrication technology that has gained enormous popularity through its paradigm shifts in manufacturing in several disciplines, including healthcare. In this past decade, we have witnessed the impact o...

Bridging pharmacology and neural networks: A deep dive into neural ordinary differential equations.

CPT: pharmacometrics & systems pharmacology
The advent of machine learning has led to innovative approaches in dealing with clinical data. Among these, Neural Ordinary Differential Equations (Neural ODEs), hybrid models merging mechanistic with deep learning models have shown promise in accura...

Machine learning and deep learning approaches for enhanced prediction of hERG blockade: a comprehensive QSAR modeling study.

Expert opinion on drug metabolism & toxicology
BACKGROUND: Cardiotoxicity is a major cause of drug withdrawal. The hERG channel, regulating ion flow, is pivotal for heart and nervous system function. Its blockade is a concern in drug development. Predicting hERG blockade is essential for identify...

Evolution of Drug Development and Regulatory Affairs: The Demonstrated Power of Artificial Intelligence.

Clinical therapeutics
PURPOSE: Artificial intelligence (AI) refers to technology capable of mimicking human cognitive functions and has important applications across all sectors and industries, including drug development. This has considerable implications for the regulat...

Artificial intelligence for small molecule anticancer drug discovery.

Expert opinion on drug discovery
INTRODUCTION: The transition from conventional cytotoxic chemotherapy to targeted cancer therapy with small-molecule anticancer drugs has enhanced treatment outcomes. This approach, which now dominates cancer treatment, has its advantages. Despite th...

Advances in artificial intelligence for drug delivery and development: A comprehensive review.

Computers in biology and medicine
Artificial intelligence (AI) has emerged as a powerful tool to revolutionize the healthcare sector, including drug delivery and development. This review explores the current and future applications of AI in the pharmaceutical industry, focusing on dr...

The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang?

Molecules (Basel, Switzerland)
The journey of drug discovery (DD) has evolved from ancient practices to modern technology-driven approaches, with Artificial Intelligence (AI) emerging as a pivotal force in streamlining and accelerating the process. Despite the vital importance of ...